Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications
- 26 January 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 6 (2) , 135-145
- https://doi.org/10.1517/14712598.6.2.135
Abstract
(2006). Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications. Expert Opinion on Biological Therapy: Vol. 6, No. 2, pp. 135-145. doi: 10.1517/14712598.6.2.135Keywords
This publication has 96 references indexed in Scilit:
- Semliki Forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunityVaccine, 2005
- Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 ExpressionJournal of Virology, 2005
- Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue virusesNature Medicine, 2004
- Sequential delivery of interferon-α gene and DCs to intracranial gliomas promotes an effective antitumor responseGene Therapy, 2004
- Recombinant Sendai Virus Expressing the G Glycoprotein of Respiratory Syncytial Virus (RSV) Elicits Immune Protection against RSVJournal of Virology, 2004
- Vaccinia as a vector for gene deliveryExpert Opinion on Biological Therapy, 2004
- Sub-genomic replicons of Tick-borne encephalitis virusArchiv für die gesamte Virusforschung, 2004
- Cross-priming of CD8+ T cells stimulated by virus-induced type I interferonNature Immunology, 2003
- Generation of CTL responses using Kunjin replicon RNAImmunology & Cell Biology, 2003
- Alphavirus vectors: development and potential therapeutic applicationsExpert Opinion on Biological Therapy, 2001